ISL
Ingalls & Snyder LLC Portfolio holdings
AUM
$2.81B
This Quarter Return
+2.47%
1 Year Return
+59.04%
3 Year Return
+136.26%
5 Year Return
+243.92%
10 Year Return
+513.41%
AUM
$2.04B
AUM Growth
+$2.04B
(-1.5%)
Cap. Flow
-$37.8M
Cap. Flow
% of AUM
-1.86%
Top 10 Holdings %
Top 10 Hldgs %
31.43%
Holding
429
New
17
Increased
76
Reduced
219
Closed
17
Top Buys
| 1 |
AbbVie
ABBV
|
$3.93M |
| 2 |
Simon Property Group
SPG
|
$3.11M |
| 3 |
FOE
Ferro Corporation
FOE
|
$2.97M |
| 4 |
Emerson Electric
EMR
|
$2.8M |
| 5 |
Corcept Therapeutics
CORT
|
$2.69M |
Top Sells
| 1 |
Peraso
PRSO
|
$10M |
| 2 |
Home Depot
HD
|
$4.32M |
| 3 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
$3.13M |
| 4 |
Johnson & Johnson
JNJ
|
$3.06M |
| 5 |
Roper Technologies
ROP
|
$2.56M |
Sector Composition
| 1 | Healthcare | 19.64% |
| 2 | Financials | 14.31% |
| 3 | Energy | 14.1% |
| 4 | Industrials | 10.99% |
| 5 | Technology | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Corcept Therapeutics
CORT
$7.35B
| $123M | 6.01% | 8,712,176 +190,377 | +2% | +$2.69M |
|
|
PXD
2
DELISTED
Pioneer Natural Resource Co.
PXD
| $101M | 4.93% | 803,219 -18,335 | -2% | -$2.31M |
|
3
Omeros
OMER
$283M
| $82M | 4% | 5,023,755 +58,198 | +1% | +$950K |
|
4
Apple
AAPL
$3.45T
| $59.2M | 2.89% | 264,291 -9,287 | -3% | -$2.08M |
|
5
Berkshire Hathaway Class B
BRK.B
$1.09T
| $55.1M | 2.69% | 264,961 -10,654 | -4% | -$2.22M |
|
6
Canadian Natural Resources
CNQ
$65.9B
| $50.2M | 2.45% | 1,886,241 -85,992 | -4% | -$2.29M |
|
7
Microsoft
MSFT
$3.77T
| $47.9M | 2.34% | 344,813 -8,020 | -2% | -$1.12M |
|
8
Hexcel
HXL
$5.02B
| $45.6M | 2.22% | 554,843 -28,306 | -5% | -$2.32M |
|
9
Williams Companies
WMB
$70.7B
| $40.3M | 1.97% | 1,674,863 -46,676 | -3% | -$1.12M |
|
10
Stratus Properties
STRS
$157M
| $35.5M | 1.73% | 1,209,817 -11,888 | -1% | -$349K |
|
11
Procter & Gamble
PG
$368B
| $34.1M | 1.66% | 273,847 -8,780 | -3% | -$1.09M |
|
12
JPMorgan Chase
JPM
$829B
| $33.2M | 1.62% | 282,074 +19,279 | +7% | +$2.27M |
|
13
Credit Acceptance
CACC
$5.78B
| $29.5M | 1.44% | 63,839 -646 | -1% | -$298K |
|
14
Citigroup
C
$178B
| $26.2M | 1.28% | 379,337 +19,448 | +5% | +$1.34M |
|
15
Alphabet (Google) Class A
GOOGL
$2.57T
| $25.1M | 1.23% | 20,583 -105 | -0.5% | -$128K |
|
16
Merck
MRK
$210B
| $24.5M | 1.2% | 291,506 -11,794 | -4% | -$993K |
|
17
Delta Air Lines
DAL
$40.3B
| $23.4M | 1.14% | 406,105 -16,707 | -4% | -$962K |
|
18
Goldman Sachs
GS
$226B
| $23.4M | 1.14% | 112,878 -1,621 | -1% | -$336K |
|
19
Pfizer
PFE
$141B
| $21.9M | 1.07% | 610,470 -8,952 | -1% | -$322K |
|
|
20
Roper Technologies
ROP
$56.6B
| $21.8M | 1.06% | 61,032 -7,167 | -11% | -$2.56M |
|
21
Bank of America
BAC
$376B
| $21.4M | 1.05% | 734,450 +32,060 | +5% | +$935K |
|
22
Cimpress
CMPR
$1.55B
| $21M | 1.03% | 159,423 -1,622 | -1% | -$214K |
|
23
Cisco
CSCO
$274B
| $20.2M | 0.99% | 408,838 -1,454 | -0.4% | -$71.8K |
|
24
Bristol-Myers Squibb
BMY
$96B
| $20M | 0.98% | 394,753 -11,484 | -3% | -$582K |
|
|
25
Johnson & Johnson
JNJ
$427B
| $19.8M | 0.97% | 153,420 -23,623 | -13% | -$3.06M |
|